Hyperliquid Strategies (NASDAQ:PURR) Stock Price Down 6.4% - Here's Why

Key Points

• Hyperliquid Strategies shares fell 6.4% to about $11.26 in Thursday trading, with 8.34 million shares changing hands—21% below average volume.
• Analyst sentiment remains broadly positive but mixed: Wall Street Zen downgraded the stock to “sell,” while Chardan Capital and Cantor Fitzgerald raised price targets. The consensus rating is “Moderate Buy,” with a target price of $20.40.
• Institutional interest has increased, with BlackRock, Paradigm Operations, Galaxy Group Investments, Pantera Capital and Feynman Point Asset Management establishing positions; institutions and hedge funds now own 9.45% of the company.

Hyperliquid Strategies Inc (NASDAQ:PURR - Get Free Report) traded down 6.4% during trading on Thursday . The company traded as low as $11.29 and last traded at $11.2590. 8,344,465 shares changed hands during trading, a decline of 21% from the average session volume of 10,588,859 shares. The stock had previously closed at $12.03.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on PURR. Wall Street Zen downgraded shares of Hyperliquid Strategies from a "hold" rating to a "sell" rating in a research note on Saturday, August 29th. Chardan Capital lifted their target price on shares of Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a "buy" rating in a research note on Friday, August 28th. Cantor Fitzgerald increased their price target on Hyperliquid Strategies from $22.60 to $34.20 and gave the stock an "overweight" rating in a research note on Thursday. Finally, Weiss Ratings upgraded Hyperliquid Strategies from a "sell (d+)" rating to a "hold (c)" rating in a report on Friday, August 28th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $20.40.

Hyperliquid Strategies Trading Down 7.0%

The firm has a 50 day moving average price of $8.45 and a two-hundred day moving average price of $7.32. The firm has a market capitalization of $2.21 billion, a price-to-earnings ratio of -1.74 and a beta of 1.89.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Hyperliquid Strategies during the 2nd quarter valued at approximately $79,842,000. Paradigm Operations LP acquired a new position in shares of Hyperliquid Strategies in the 2nd quarter valued at about $44,936,535. Galaxy Group Investments LLC acquired a new position in Hyperliquid Strategies in the fourth quarter valued at approximately $15,167,000. Pantera Capital Partners LP bought a new position in Hyperliquid Strategies during the 4th quarter worth $14,545,000. Finally, Feynman Point Asset Management LLC bought a new position in shares of Hyperliquid Strategies during the fourth quarter worth about $14,431,000. 9.45% of the stock is owned by institutional investors and hedge funds.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.